{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T09:44:58Z","timestamp":1776851098227,"version":"3.51.2"},"reference-count":75,"publisher":"Informa UK Limited","issue":"5-6","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"],"published-print":{"date-parts":[[2025,7,3]]},"DOI":"10.1080\/21678421.2025.2475893","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T01:21:12Z","timestamp":1741742472000},"page":"389-398","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Minimum clinically important difference for drug effectiveness in an area of patient-oriented therapeutic goals in amyotrophic lateral sclerosis"],"prefix":"10.1080","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9579-5341","authenticated-orcid":false,"given":"Adriano","family":"Chi\u00f2","sequence":"first","affiliation":[{"name":"Rita Levi Montalcini Department of Neuroscience, University of Turin","place":["Turin, Italy"]},{"name":"Department of Neuroscience and Mental Health, Azienda Ospedaliero Universitaria Citt\u00e0 della Salute e della Scienza di Torino","place":["Turin, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9026-0268","authenticated-orcid":false,"given":"Juliette","family":"Foucher","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet","place":["Stockholm, Sweden"]},{"name":"Department of Neurology, Karolinska University Hospital","place":["Stockholm, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly G","family":"Gwathmey","sequence":"additional","affiliation":[{"name":"Department of Neurology, Virginia Commonwealth University","place":["Richmond, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5327-7204","authenticated-orcid":false,"given":"Caroline","family":"Ingre","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet","place":["Stockholm, Sweden"]},{"name":"Department of Neurology, Karolinska University Hospital","place":["Stockholm, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31287-4"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00068"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.107986"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab242"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006855"},{"key":"e_1_3_2_7_1","article-title":"Guideline on clinical investigation of medicinal products for the treatment of amyotrophic lateral sclerosis (ALS)","author":"European Medicines Agency (EMA)","year":"2015","unstructured":"European Medicines Agency (EMA). Guideline on clinical investigation of medicinal products for the treatment of amyotrophic lateral sclerosis (ALS). Committee for Medicinal Product for Human Use (CHMP). 2015. Available from: https:\/\/www.tga.gov.au\/sites\/default\/files\/2024-07\/guideline_on_the_clinical_products_for_the_treatment_of_amyotrophic_lateral_sclerosis_als_.pdf","journal-title":"Committee for Medicinal Product for Human Use (CHMP)"},{"key":"e_1_3_2_8_1","unstructured":"Food and Drug Administration (FDA). Amyotrophic lateral sclerosis: developing drugs for treatment. Guidance for industry. [Internet]. 2019. Available from: https:\/\/www.fda.gov\/drugs\/guidance-compliance-regulatory-information\/guidances-drugs"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2019.100486"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2005.0k375.x"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(89)90005-6"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.spinee.2007.01.008"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(99)00210-5"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2014.942668"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.3109\/17482960903093710"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2022.2153607"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S153196"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmr.2008.02.002"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.4155\/cli.11.127"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403033300901"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91680-3"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2020.1771734"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2023.102588"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.82.10_supplement.P4.094"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-325253"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002251"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01271-2"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2021.2016838"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2023.2260832"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.4490"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207483"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11483-3"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70221-7"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr351"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-306589"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-310176"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2022.2154678"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000862"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10714-3"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00398.2021"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2204705"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.637548"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells11193128"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00035"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aai7866"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhx301"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab322"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00135"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000728"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2024.2361695"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1080\/01616412.2022.2096004"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.103162"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.947347"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.890425"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2023.2249515"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-328194"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.3109\/17482968.2011.607500"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2014(08)02"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20151"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-06191-z"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209502"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010903"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01904-6"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2019.1581610"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2018.1425455"},{"key":"e_1_3_2_66_1","unstructured":"Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic review report: Edaravone (Radicava): (Mitsubishi Tanabe Pharma Corporation): Indication: for the treatment of amyotrophic lateral sclerosis (ALS). [Internet]. 2019. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK542526\/"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202002-169OC"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13525"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756286419857040"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002786"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2020.1788092"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26285"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1177\/2374373520951672"},{"key":"e_1_3_2_74_1","first-page":"S41","article-title":"The Montreal model: the challenges of a partnership relationship between patients and healthcare professionals","volume":"27","author":"Pomey MP","year":"2015","unstructured":"Pomey MP, Flora L, Karazivan P, Dumez V, Lebel P, Vanier MC, et\u00a0al. The Montreal model: the challenges of a partnership relationship between patients and healthcare professionals. Sante Publique. 2015;27:S41\u2013S50.","journal-title":"Sante Publique"},{"key":"e_1_3_2_75_1","unstructured":"The Joint Commission. Advancing effective communication cultural competence and patient- and family-centered care: a roadmap for hospitals. [Internet]. 2010. Available from: https:\/\/www.jointcommission.org\/-\/media\/tjc\/documents\/resources\/patient-safety-topics\/health-equity\/aroadmapforhospitalsfinalversion727pdf.pdf?db=web&hash=AC3AC4BED1D973713C2CA6B2E5ACD01B"},{"key":"e_1_3_2_76_1","unstructured":"Institute of Medicine (US) Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century [Internet]. Washington (DC): National Academies Press (US); 2001. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK222274\/"}],"container-title":["Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21678421.2025.2475893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T15:51:27Z","timestamp":1753199487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21678421.2025.2475893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":75,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2025,7,3]]}},"alternative-id":["10.1080\/21678421.2025.2475893"],"URL":"https:\/\/doi.org\/10.1080\/21678421.2025.2475893","relation":{},"ISSN":["2167-8421","2167-9223"],"issn-type":[{"value":"2167-8421","type":"print"},{"value":"2167-9223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iafd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iafd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-07-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}